What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have been discharged after treatment for COVID-19 pneumonia?
Recommendation ID NG186/2 Question What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have